Pfm Health Sciences, LP Dynavax Technologies Corp Transaction History

Pfm Health Sciences, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $10.8 Million - $14.5 Million	-1,100,453 Reduced 28.92%	2,704,917 $34.9 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $6.87 Million - $10.9 Million	521,800 Added 15.89%	3,805,370 $53.5 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $2.68 Million - $5.81 Million	292,800 Added 9.79%	3,283,570 $63.1 Million
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $245,774 - $601,260	53,780 Added 1.83%	2,990,770 $29.4 Million
Q3 2020 Nov 16, 2020	BUY	$4.32 - $11.7 $7.75 Million - $21 Million	1,793,464 Added 156.84%	2,936,990 $12.7 Million
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $3.36 Million - $10.4 Million	1,143,526 New	1,143,526 $10.1 Million

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.56B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.